Hives

FDA Approves Dupixent for Chronic Spontaneous Urticaria in Young Children

Physician’s Briefing

FDA Approves Dupixent for Chronic Spontaneous Urticaria in Young Children

16 hours ago

1 min read

Study Compares Benefits, Harms of Treatments for Chronic Hives

Physician’s Briefing

Study Compares Benefits, Harms of Treatments for Chronic Hives

23 Jul 2025

1 min read

FDA Approves Once-Monthly Andembry for Hereditary Angioedema

FDA Approves Once-Monthly Andembry for Hereditary Angioedema

20 Jun 2025

2 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com